Back to search

United States· US:49967-202_e4c50d8c-3ab1-4281-bd1a-34e90549ac30

MAYBELLINE NEW YORK INSTANT AGE REWIND ERASER TREATMENT MAKEUP OCTINOXATE BROAD SPECTRUM SPF 20 SUNSCREEN PLUS PROVITAMIN B5

A octinoxate product containing octinoxate, registered in United States by L'Oreal USA Products Inc. The same ATC class is registered in 2 of our 19 countries.

ATC D02BA02US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedMAYBELLINE NEW YORK INSTANT AGE REWIN…ATCD02BA02REGISTER NO.US:49967-202_e4c50d8c…PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Octinoxate is registered in 2 of 19 countries.

Countries holding a registration under ATC D02BA02 (octinoxate), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 1 of them publish a price we can compare per daily dose

Octinoxate · ATC D02BA02

2 / 19 countries

  • Canada
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
OCTINOXATE
Manufacturer
L'Oreal USA Products Inc
Country
United States (US)
ATC code
D02BA02
ATC class
Octinoxate
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    49967-202-01
  • ndc11
    4996720201
    20 mL in 1 BOTTLE (49967-202-01)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Octinoxate in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All octinoxate products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b88b3530-d922-4c5f-850a-c39cfcb78b0b
GET /v1/drugs/b88b3530-d922-4c5f-850a-c39cfcb78b0b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "TOPICAL",
  "source": "ndc",
  "strength": "75",
  "substance": "OCTINOXATE",
  "productndc": "49967-202",
  "dosage_form": "LOTION",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": "M020",
  "marketing_category": "OTC MONOGRAPH DRUG"
}

See everything about octinoxate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.